GSK Achieves US Drugs Fix
Foley, Stephen, The Independent (London, England)
GlaxoSmithKline will return two of its best-selling drugs to the US market within the next few weeks, it said yesterday, after agreeing plans to fix problems at its Puerto Rican drug factory.
US regulators seized defective supplies of the drugs last month and they have been off the market since then, costing GSK about pounds 200m in lost sales.
GSK shares jumped more than 6 per cent on relief that the dbcle could soon be over, but the company also revealed that it had received a subpoena from the US Attorney's office, which has opened an investigation into GSK's manufacturing processes in Puerto Rico.
The US regulator, the Food & Drug Administration, …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: GSK Achieves US Drugs Fix.
Contributors: Foley, Stephen - Author.
Newspaper title: The Independent (London, England).
Publication date: April 29, 2005.
Page number: 58.
© 2009 The Independent - London.
Provided by ProQuest LLC. All Rights Reserved.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset